Costs were overestimated

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7016.1372 (Published 18 November 1995) Cite this as: BMJ 1995;311:1372
  1. T M Reynolds
  1. Consultant chemical pathologist Clinical Chemistry Department, Burton Hospitals NHS Trust, Burton upon Trent, Staffordshire DE13 0RB

    EDITOR,--J Fletcher and colleagues' paper on using decision analysis to evaluate screening for Down's syndrome is valuable, but several extra factors need to be considered.1 The authors state that screening causes anxiety but fail to mention the reassurance that it gives to many women. In addition, they based their study on use of the triple test despite the considerable body of evidence showing that a double test is as effective.2 3 Indeed, the national external quality assurance scheme's reports on Down's …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription